Pharmacokinetics of Atenolol and Metoprolol Administered together with Piroxicam
β Scribed by Hildegard Spahn; Peter Langguth; Dorit Krauss; Wilhelm Kirch; Ernst Mutschler
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 257 KB
- Volume
- 320
- Category
- Article
- ISSN
- 0365-6233
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The influence of inflammatory disease on the pharmacokinetics of atenolol and metoprolol was investigated after administering single oral 100 mg doses of the drugs to six subjects. Each subject had a respiratory tract infection with an erythrocyte sedimentation rate (ESR) of over 20 mm in the first
In a double-blind, randomised, cross-over study, the pharmacokinetic/dynamic effects and subjective symptoms of a new controlled-release (CR) formulation of metoprolol (50 and 100 mg) have been compared with atenolol (50 mg) and placebo in 20 elderly healthy subjects. The metoprolol CR formulation d